Actelis Networks, Inc.
A filing-based review of operating performance, liquidity, equity financing, material corporate developments and documented capital-market events.
1. Business and financial performance
An OTC quotation can change liquidity, investor access, spreads and institutional eligibility. It does not establish that the company’s underlying networking technology lacks value, but it can make financing more expensive.
Actelis disclosed in July 2026 that Nasdaq would officially delist its common stock after an April 10 trading suspension. Its shares were quoted on OTCQB under ASNS. The company’s June 2026 10-Q also described the liquidity and pricing risks of OTC quotation.
2. Liquidity and going concern
A separate, filing-supported assessment of liquidity and going-concern status is not established in this edition.
3. Equity financing and dilution
Avoid describing ASNS as a currently Nasdaq-listed stock. The trading venue and any relisting developments should be checked before each publication update.
4. Exchange listing and trading events
No exchange-listing or trading event has been established from the source material included in this edition.
5. Strategic developments and corporate actions
An OTC quotation can change liquidity, investor access, spreads and institutional eligibility. It does not establish that the company’s underlying networking technology lacks value, but it can make financing more expensive.
Primary document: Review underlying regulatory source ↗
6. Evidence ledger
7. Research conclusion
The evidence included in this edition is insufficient for a directional investment conclusion.
Documented filing analysis: Public float, trading venue and funding access
Actelis Networks’ quarterly filing for June 30, 2026 reports 28,837,580 common shares outstanding as of August 11, 2026. That is a dated share count, not a fully diluted count; warrants, options and subsequent issuances can alter the ownership denominator.
The company’s Form 10-Q lists no securities registered under Section 12(b) at that reporting date. The distinction between exchange registration and OTC quotation matters for trading access and capital-market eligibility, but is not itself a measure of operating product quality.
Primary document: Open underlying filing or issuer document ↗
Independent research and non-compensation disclosure
Unsolicited, non-sponsored proprietary research. AnalystPitch.com independently selected Actelis Networks, Inc. as the subject of this report and initiated its preparation and publication on its own initiative. Actelis Networks, Inc. did not request, commission, sponsor, direct, or authorize this publication and had no involvement in the research process, editorial decisions, or approval of the report.
Compensation received or promised for this publication: US$0.00. AnalystPitch.com states that it has received no cash, securities, warrants, options, expense reimbursement, or other direct or indirect consideration from Actelis Networks, Inc. or anyone acting on its behalf in exchange for preparing, publishing, or distributing this report, and that no such consideration has been promised. This report is not paid securities promotion or issuer-sponsored research.
Section 17(b) transparency. Section 17(b) of the Securities Act of 1933 addresses certain securities publicity published for consideration received directly or indirectly from an issuer, underwriter, or dealer. The compensation statement above describes the circumstances of this report; it is not a claim that the SEC has reviewed, approved, or certified the report or this disclosure.
Other potential conflicts. The absence of payment for this publication does not by itself establish the absence of other financial interests or relationships. Any material securities holdings, financing arrangements, advisory engagements, or other relevant conflicts involving the publisher or its responsible contributors should be separately disclosed where applicable.
This publication is informational research, not personalized investment advice, an offer to sell securities, or a solicitation to purchase securities.
9. Primary documents
Primary referenced regulatory filing or source ↗
SEC EDGAR — search subsequent company filings ↗
Information cutoff: 13 October 2026. Not all financial line items have been independently recalculated. This report does not purport to reproduce a full audited financial model. Information can become outdated after the cutoff.